| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.6975 | 
      | Human Intestinal Absorption | HIA+ | 0.7855 | 
      | Caco-2 Permeability | Caco2- | 0.9398 | 
      | P-glycoprotein Substrate | Substrate | 0.5905 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8782 | 
                                                     | Non-inhibitor | 0.7968 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8921 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6068 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8116 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8923 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6035 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9084 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9296 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9513 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9289 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9193 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7728 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9813 | 
                                                                    | Non-inhibitor | 0.6865 | 
      | AMES Toxicity | AMES toxic | 0.5776 | 
      | Carcinogens | Non-carcinogens | 0.9589 | 
      | Fish Toxicity | High FHMT | 0.8840 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9542 | 
      | Honey Bee Toxicity | High HBT | 0.6404 | 
      | Biodegradation | Not ready biodegradable | 0.6259 | 
      | Acute Oral Toxicity | III | 0.4045 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7144 |